skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Looking to reposition out of Oil&Gas. The noted companies have been beaten down. How would you rank for a 3 year horizon. Highest to lowest. Any other names you would add to this list?

Read Answer Asked by Christopher on July 26, 2022

Q: Would appreciate your views on this morning's blockbuster announcement. The SP has been very lethargic over the past year but this could finally move the yardsticks.

CINCINNATI, April 26, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is very pleased to announce the execution of a national insurance contract with a top five health insurer in the United States1.

Management Commentary

“The execution of this national insurance contract with the largest commercial payer in the United States is a major milestone for Quipt and serves as a further accelerant to our ambitious long term growth plans. The national contract is expected to be meaningful as we continue to expand into new states, broadening our operating footprint over a much wider geography. When we make an acquisition, we will be able to immediately leverage the national contract, which is extremely powerful in terms of capturing as many eligible patients as possible,” said Greg Crawford, Chairman and CEO of Quipt. “Moreover, we feel there's still a lot of opportunity for us to go after more national contracts, which would provide the opportunity to add additional payers, and we will continue to work with other large commercial payers to help them better understand our strong patient centric model and the benefits to patients and payors alike. The new national insurance contract, extremely favorable demographics, and our robust operating platform, put us in an industry leading position to provide high touch at home clinical respiratory services throughout the country.”

Read Answer Asked by karl on April 26, 2022

Q: Hello Peter and Team

I have above stocks in my TFSA account. I am down CAE 10%, NVEI 47%, ENGH 17%, KXS 24%, LSPD 12%, QIPT 18%.

Normally I will consider all of them as good growth stocks but with the rotation now hapening in the market, I am wondering if I should keep them for the next 12 months or I should switch to more value stocks.

I value you opinion


Read Answer Asked by Raoul on January 17, 2022

Q: I am having difficulty making sense of the recent loss for this company. The results appear to be penalized by losses applying to a change in the fair value of debentures as well as derivatives which together are greater than the EBITDA earnings. I was wondering how relevant these are to the company's prospects and whether the resulting valuation justified the fall in the share price. Thank you for your response.

Read Answer Asked by Mike on August 06, 2021

Q: Regarding Tak's question about selling QIPT at a loss and buying WELL. There are QIPT warrants exerciseable at CAD $6.40 up to June 29th. It is possible that warrant holders have been shorting the stock, resulting in the recent price deterioration. Since the warrant expiry is so close, it might be worth waiting until early July to see if the share price rebounds absent the short pressure. I own both and am waiting until July before making a decision to hold or sell QIPT.

Read Answer Asked by David on June 24, 2021